SkinBioTherapeutics "delighted" with psoriasis study results, with 76% reporting less itchy skin – Proactive Investors UK

() Stuart Ashman joins Proactive London to discuss results from a study of people suffering from psoriasis that received its immune system-modulating food supplement delivering results that exceeded expectations.

In all 91 people with the condition completed the 56-day self-managed consumer study with 76% of the group reporting their skin felt less itchy, and 75% saying it appeared less red.

Ashman says the findings from the assessment of AxisBiotix-Ps, developed in collaboration with partner Winclove Probiotics, will pave the way for a commercial launch of the product in the fourth quarter.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

See the original post:
SkinBioTherapeutics "delighted" with psoriasis study results, with 76% reporting less itchy skin - Proactive Investors UK